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Abstract
The partially disordered Chibby (Cby) is a conserved nuclear protein that antagonizes the
Wnt/β-catenin signaling pathway. By competing with the Tcf/Lef family proteins for binding
to β-catenin, Cby abrogates the β-catenin-mediated transcription of Wnt signaling genes.
Additionally, upon phosphorylation on S20 by the kinase Akt, Cby forms a complex with
14-3-3 to facilitate the nuclear export of β-catenin, which represents another crucial mecha-
nism for the regulation of Wnt signaling. To obtain a mechanistic understanding of the 14-3-3/
Cby interaction, we have extensively characterized the complex using X-ray crystallography,
nuclear magnetic resonance (NMR) spectroscopy, and isothermal titration calorimetry (ITC).
The crystal structure of the human 14-3-3ζ/Cby protein-peptide complex reveals a canonical
binding mode; however the residue at the +2 position from the phosphorylated serine is
shown to be uniquely oriented relative to other solved structures of 14-3-3 complexes. Our
ITC results illustrate that although the phosphorylation of S20 is essential for Cby to recognize
14-3-3, residues flanking the phosphorylation site also contribute to the binding affinity. How-
ever, as is commonly observed in other 14-3-3/phosphopeptide crystal structures, residues of
Cby flanking the 14-3-3 binding motif lack observable electron density. To obtain a more de-
tailed binding interface, we have completed the backbone NMR resonance assignment of
14-3-3ζ. NMR titration experiments reveal that residues outside of the 14-3-3 conserved bind-
ing cleft, namely a flexible loop consisting of residues 203-210, are also involved in binding
Cby. By using a combined X-ray and NMR approach, we have dissected the molecular basis
of the 14-3-3/Cby interaction.
Introduction
Chibby (Cby) is a small (14.5 kDa), highly conserved protein that functions as a Wnt/β-catenin
signaling antagonist [1]. While the Wnt pathway plays crucial roles in cell proliferation and dif-
ferentiation, embryonic development and tissue homeostasis, its dysregulation contributes to
the pathogenesis of an array of human disorders, including cancer [2,3]. Because of this,
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pharmacological modulation of the pathway has great therapeutic potential for disease treat-
ments [4,5,6,7].
Activation of the Wnt pathway promotes the stabilization of the transcriptional co-activator
β-catenin within the cytoplasm, allowing it to translocate to the nucleus and bind to TCF/LEF
(T cell factor/lymphoid enhancer factor) transcription factors to activate Wnt target genes
[8,9,10,11]. Multiple regulatory strategies employed by the cell focus on various stages of the
Wnt pathway [12], with β-catenin being a focal point. Cby is one such regulatory protein, sup-
pressing β-catenin-mediated signaling via two distinct molecular mechanisms. First, in the nu-
cleus, it competes with the TCF/LEF transcription factors for binding to β-catenin [1].
Secondly, Cby facilitates β-catenin export from the nucleus in conjunction with the proteins
14-3-3 and the nuclear export receptor chromosomal region maintenance 1 (CRM1) [13,14].
In this mode of regulation, Cby forms a stable trimolecular complex with 14-3-3 and β-catenin
[13]. Interestingly, binding of 14-3-3 to Cby also leads to an enhanced interaction between Cby
and CRM1, promoting nuclear exclusion of Cby-bound β-catenin [14].
The ability of the 126-residue human Cby to function as a scaffold protein likely arises from
its partially disordered nature. It is well documented that intrinsically disordered proteins bind
to multiple targets by adopting different conformations or via linear motifs located at different
regions in the proteins [15,16,17]. Previous work has shown that Cby consists of an unstruc-
tured N-terminus and contains a coiled-coil motif within its C-terminus (residues 73–100) that
enables dimerization [18,19]. Cby uses its C-terminus to bind to β-catenin [1], although resi-
dues critical for this interaction have yet to be elucidated. 14-3-3 recognizes the motif 16RKSA
(pS)LS22 located in the disordered N-terminus of Cby, when the serine 20 residue is phosphor-
ylated by the kinase Akt [13]. In this manner, N- and C-terminal binding modules on Cby
work together to facilitate the nuclear export of β-catenin; however, how Cby forms such com-
plexes from a structural standpoint remains unknown. Our work here focuses on elucidating
the binding mode between Cby and 14-3-3.
The 14-3-3 proteins, which consist of seven isoforms in mammals (β, ε, η, γ, τ, z and σ),
function as adaptor molecules and are involved in a large range of cellular processes, including
apoptosis, DNA damage response and transcriptional regulation [20]. Structurally, the ~30
kDa 14-3-3 proteins assemble into homo- or heterodimers, with each monomer composed of
nine anti-parallel alpha-helices (αA-αI) [21]. An amphipathic groove composed of helices αC,
αE, αG, and αI comprise the ligand-binding interface. Generally, 14-3-3 isoforms recognize
three consensus binding motifs: RXX(pS/pT)XP (mode I), RXXX(pS/pT)XP (mode II) and
(pS/pT)X1-2-COOH (mode III) where pS/pT represents phosphorylated serine/threonine
[22,23]. However, there are several 14-3-3 binding partners that deviate significantly from
these canonical motifs, including examples of non-phosphorylated partners [24,25].
With hundreds of binding partners discovered to date [26], the 14-3-3 proteins are classified
as signaling hub proteins. Interestingly, many well-structured hub proteins are found to preferen-
tially bind to unstructured proteins [15]. In fact, the vast majority of 14-3-3 binding motifs are ei-
ther found or predicted to be within disordered regions [27,28]. While this is due in large part to
the phospho-dependence of 14-3-3 interactions, as kinases predominantly target unstructured re-
gions for phosphorylation [29], the structural plasticity of 14-3-3 binding motifs and their neigh-
bouring residues allows 14-3-3 proteins to target many different proteins with high specificity.
14-3-3 targets are hypothesized to bind to 14-3-3 via primary and secondary interactions
(discussed by Yang et al. [21]). The primary interactions are made between the 14-3-3 binding
motif (including the pS/pT residue) of the target and a conserved binding groove in the 14-3-3
protein. Secondary interactions occur when residues flanking the target’s 14-3-3 binding-motif
contact regions outside of the conserved 14-3-3 binding groove. While various crystal struc-
tures of 14-3-3 complexes have been solved, the majority of them have been co-crystallized
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with short peptides. Observable electron density is typically only present for 4–10 residues
flanking the phosphorylated residue of the target peptide. While this provides a structural basis
for the primary contacts of the interaction, information regarding the secondary contacts is
limited. To date, only one (nearly) full-length, globular partner has been co-crystallized with
14-3-3 [30].
The disordered Cby is able to interact with at least three of the seven 14-3-3 isoforms (ε, η
and z) [13]. Its 14-3-3 binding motif (16RKSA(pS)LS22) closely resembles the mode II motif
(RXXX(pS/pT)XP), the difference being that Cby contains a serine instead of proline at the +2
position from the phosphoserine. It is noteworthy that even though proline is found to be the
+2 residue in ~ 50% of known 14-3-3 binding motifs, serine is in fact the second most com-
monly found amino acid at that position [25]. To our knowledge, no 14-3-3/phosphopeptide
structure with serine as the +2 residue has been determined to date.
In this work, the crystal structure of 14-3-3z in complex with an 18-residue phosphorylated
Cby-derived peptide was solved to reveal the primary binding interactions. Secondary interac-
tions between 14-3-3 and the Cby peptide were further investigated by using nuclear magnetic
resonance (NMR) spectroscopy and isothermal titration calorimetry (ITC). By combining the
X-ray and NMR techniques, we were able to obtain additional molecular details of the binding
interface of Cby on 14-3-3. Notably, the backbone assignment of 14-3-3z completed in this
work will also facilitate mapping of regions on the 14-3-3z surface that are involved in binding
other targets.
Results
Phosphorylation of serine 20 on Cby is critical for its binding to 14-3-3ζ
A previous study by Li et al. [13] showed that S20 of Cby is essential for its interaction with
14-3-3, with the binding being regulated by the phosphorylation of this serine residue. To quan-
titatively assess the importance of the phosphorylation of S20 to the complex formation with
14-3-3z, we have used ITC to measure the affinities of a Cby peptide (12KTPPRKSASLSNL24)
encompassing the 14-3-3 binding motif, in both its non-phosphorylated and phosphorylated
forms, to 14-3-3z. The same peptides containing the phospho-mimetic mutants S20D and S20E
were also included in this study. Our data show that only the phosphorylated Cby peptide was
able to interact with 14-3-3z (KD ~ 15 μM, Table 1), while the other three peptides display no
observable binding (S1 Fig). Importantly, the phospho-mimetic mutations were unable to res-
cue the binding, indicating that the Cby/14-3-3z association is driven by the phosphate group
on S20.
Flanking residues of the consensus 14-3-3 binding motif play important
roles in the Cby/14-3-3ζ association
Next, we assessed the contributions of residues flanking the consensus 14-3-3 binding motif of
Cby to the interaction with 14-3-3z. The results of our ITCmeasurements show that a 7-mer
Cby peptide (16RKSA(pS)LS22) comprising the minimal 14-3-3 binding motif bound to 14-3-3z
with a KD of ~44 μM (Table 1, S2 Fig). Interestingly, phosphopeptides of increasing length ex-
hibit a systematic increase in binding affinity to 14-3-3z (the results are summarized in Table 1
and the thermograms are shown in S2 Fig). First, a Cby 11-mer peptide which contains 4 addi-
tional residues (12KTPP15) than the Cby 7-mer peptide (16RKSA(pS)LS22) bound with more
than two-fold greater affinity than the Cby 7-mer, with a KD of ~18 μM. A Cby 13-mer, with a 2
residue C-terminal extension to the 11-mer (23NL24), bound with only slightly higher affinity,
with a KD of ~15 μM. Lastly, an 18-mer, which contains a five-residue C-terminal extension to
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the 13-mer (25HSLDR29), bound with nine-fold greater affinity compared to the 7-mer, with a
KD of ~5 μM. The results clearly indicate that residues flanking the binding-motif on Cby play
significant roles in mediating the interaction with 14-3-3z.
Molecular basis of the interaction between 14-3-3ζ and the non-
canonical mode II binding-motif of Cby
We used X-ray crystallography to elucidate the molecular basis of the 14-3-3z/Cby interac-
tion. Purified 14-3-3z protein was co-crystallized with the phosphorylated Cby 18-mer
(12KTPPRKSA(pS)LSNLHSLDR29) and diffraction data were collected to a resolution of 2.41
Å (Table 2). The 14-3-3z protein, which crystallized as the typical cup-shaped dimer [20],
has the Cby peptide bound in an extended conformation to each 14-3-3 monomer (Fig 1A).
The dimer comprises the asymmetric unit of the crystal, and the visible electron density was
slightly more extensive for the peptide bound to the B-chain of the dimer. Thus, of the 18 res-
idues in the Cby peptide, eight residues, 18SA(pS)LSNLH25, were resolved in the peptide
bound to the 14-3-3 B-chain (Fig 1B) and seven residues, 18SA(pS)LSNL24, for that bound to
the 14-3-3 A-chain (not shown). Both bound peptides adopted similar conformations and
made the same interactions with the 14-3-3 protein. The lack of observable electron density
for the remaining residues suggests that they remain flexible within the complex.
The overall structural features of the 14-3-3z/Cby complex are similar to that of other
14-3-3z/phosphopeptide complexes. The Cby peptide occupies the conserved binding groove
of 14-3-3 with the same orientation as other phosphopeptides previously characterized. The
hydrogen bonding potential of the phosphate group on pS20 is fully realized, with two
Table 1. Thermodynamic parameters for the binding of phosphorylated Cby peptides to 14-3-3.
14-3-3 construct in ITC
Cell
Peptide na Kd
b
(10-6 M)
ΔHb
(kcal/mol)
TΔSb
(kcal/mol)
ΔGb
(kcal/mol)
14-3-3ζ
Cby 7-mer16RKSA(pS)LS22 1.01 43.5 ± 1.9 -3.35 ± 0.06 2.60 -5.95 ± 0.03
Cby 11-mer12KTPPRKSA(pS)LS22 0.95 17.5 ± 0.6 -3.26 ± 0.02 3.23 -6.49 ± 0.02
Cby 13-mer12KTPPRKSA(pS)LSNL24 1.00 14.5 ± 0.6 -2.63 ± 0.02 3.97 -6.60 ± 0.02
Cby 18-mer12KTPPRKSA(pS)LSNLHSLDR29 0.96 4.6 ± 0.2 -4.35 ± 0.05 2.93 -7.28 ± 0.03
Cby 7-mer S22P16RKSA(pS)LP22 1.03 2.9 ± 0.05 -6.16 ± 0.01 1.39 -7.55 ± 0.01
Cby 13-mer S22P12KTPPRKSA(pS)LPNL24 1.06 1.1 ± 0.03 -4.64 ± 0.01 3.49 -8.13 ± 0.02
Cby 18-mer S22P12KTPPRKSA(pS)
LPNLHSLDR29
1.05 0.36 ± 0.01 -8.03 ± 0.02 0.76 -8.79 ± 0.02
Cby 18-mer L24A12KTPPRKSA(pS)
LSNAHSLDR29
0.99 21.3 ± 1.7 -1.56 ± 0.05 4.81 -6.37 ± 0.05
14-3-3ζ K49A
Cby 18-mer WT12KTPPRKSA(pS)
LSNLHSLDR29
1.01 3.8 ± 0.3 -4.16 ± 0.05 3.23 -7.39 ± 0.05
Cby 18-mer S22P12KTPPRKSA(pS)
LPNLHSLDR29
1.07 1.9 ± 0.2 -7.13 ± 0.03 0.67 -7.80 ± 0.06
14-3-3ζΔC12
Cby 13-mer12KTPPRKSA(pS)LSNL24 0.99 14.9 ± 0.9 -2.08 ± 0.03 4.50 -6.58 ± 0.04
Cby 18-mer12KTPPRKSA(pS)LSNLHSLDR29 1.04 6.8 ± 0.4 -3.35 ± 0.06 3.70 -7.05 ± 0.03
A duplicate set of experimental values for all ITC experiments is reported in S1 Table.
a Binding stoichiometry of monomeric 14-3-3 and Cby peptide.
bKd is the dissociation constant ΔH, ΔS and ΔG are the change in enthalpy, entropy and Gibbs free energy upon binding at T = 298.15 K, respectively.
doi:10.1371/journal.pone.0123934.t001
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hydrogen bonds made to each of R56 and R127, and another hydrogen bond to the side-chain
hydroxyl of Y128 (Fig 1C); 3 water molecules and the side chain of Cby-S22 mediate four addi-
tional hydrogen bonds to the phosphate oxygens. Thus, each of the phosphate oxygens has 3
hydrogen bonding partners positioned in an ideal tetrahedral arrangement, explaining why
mutation of S20 to D or E fails to promote high affinity binding of Cby to 14-3-3z. The peptide
is further coordinated by hydrogen bonds between the side-chain of 14-3-3z-N224 with the
backbone nitrogen and carbonyl of Cby-A19, the carboxamide of 14-3-3z-N173 to the back-
bone nitrogen of Cby-L21, and the side-chain of either E180 (chain-C) or W228 (chain-D) of
14-3-3z to the hydroxyl group on the side-chain of Cby-S18. Intra-chain contacts exist within
the Cby peptide as well. On chain-D of the model, consisting of residues 18SA(pS)LSNLH25,
the pS20 amide is hydrogen bonded to the N23 side-chain, the phosphate group itself on S20
hydrogen bonds with the hydroxyl group on the S22 side-chain, the pS20 carboxyl contacts
both the amide and the side-chain of N23 and the carboxyl of L21 contacts the amide of L24.
An S22P mutation to Cby enhances its interaction with 14-3-3ζ
As mentioned, Cby comprises a serine (S22) in the +2 position to the phosphoserine, as op-
posed to the canonical proline. A comparison between the 14-3-3z/Cby structure with other
Table 2. Crystallographic data collection and refinement statistics.
Data Collection
Wavelength (Å) 1.54179
Cell Parameters
a, b, c (Å) 70.83, 71.96, 130.99
Space group P212121
Resolution (Å) 65.49–2.41 (2.53–2.41)
Total reﬂections 139,670 (16,075)
Unique reﬂections 26,474 (3445)
Rmerge 0.072 (0.516)
Completeness (%) 98.4 (89.5)
Multiplicity 5.3 (4.7)
I/σ(I) 13.9 (3.2)
Reﬁnement
Rwork/Rfree (%) 0.203/0.256
RMSD from ideal values
Bonds (Å) 0.008
Angles (°) 1.12
Overall mean B values (Å2)
Protein 21.71
Peptide 26.69
Solvent 19.22
Number of amino acid residues per asymmetric unit 464
Number of water molecules 147
Ramachandran plot
Favoured regions (%) 98
Allowed regions (%) 1.8
Disallowed regions (%) 0.2
Cβ deviations greater than 0.25 Å 0
Values in parentheses refer to the highest resolution shell.
doi:10.1371/journal.pone.0123934.t002
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14-3-3z/phosphopeptide complexes with different +2 residues [including the canonical proline
(Raf1), aspartate (PKCε [31]), glycine (Histone H3 [32]), threonine (β2 integrin [33]) and leu-
cine (α4 integrin [34])], reveals that the S22 side chain is oriented uniquely, projecting between
14-3-3z residues R56 and K49 (Fig 2). Also, superimposition of these peptides onto Cby dem-
onstrates that the backbones of residues -2 to +1 typically align well but diverge quickly C-ter-
minally from the +2 residue.
With the side chain on Cby-S22 distinctively positioned relative to other +2 residues in
14-3-3/phosphopeptide structures, we sought to determine if mutating this serine to the ca-
nonical proline would have a significant effect on Cby’s interaction with 14-3-3z. The same
7-mer, 13-mer and 18-mer Cby phosphopeptides used previously, but now containing the
S22P mutation, were used in ITC experiments to determine the binding affinity to 14-3-3z
(Table 1, S2 Fig). Interestingly, for all S22P Cby peptides, the binding affinity was approxi-
mately 15-fold tighter for each peptide respective to its wild-type counterpart (for 7-mer,
KD ~3 versus ~44 μM; for 13-mer, KD ~1 versus ~15 μM; for 18-mer, KD ~360 nM versus
~5 μM). The increases in binding affinity for the three S22P mutant peptides were all due to
more negative ΔH of binding. Moreover, the flanking residues within the S22P Cby peptides,
like the WT, appear to play a role in the interaction as well. The Cby S22P 18-mer bound ~9
fold tighter than the S22P 7-mer, similar to the difference observed between the WT Cby
18-mer and 7-mer peptides.
In numerous crystal structures of 14-3-3 proteins in complex with phosphorylated S/T
peptides, the conserved K49 (numbering refers to the z isoform) side-chain is observed form-
ing a hydrogen bond with the phosphate group on pS/pT (illustrated in S3 Fig with an eluci-
dated 14-3-3z/Raf1 structure). With Cby’s S22 side-chain juxtaposed between 14-3-3z
residues K49 and R56, the K49 side-chain is sterically hindered from contacting pS20. As
such, we speculated that the increases in binding affinity to 14-3-3z observed for the S22P
mutant peptides might be the result of the favorable contacts between K49 and pS20 facilitat-
ed by the proline-induced conformational changes. To test this, a K49A mutation was intro-
duced into 14-3-3z and ITC titrations were performed with 18-mer WT and S22P Cby
peptides. Interestingly, the data show that the K49A mutation only had a minor effect
(ΔΔG ~ 0.1 kcal/mol) on the binding to the WT Cby peptide, however, the mutant bound
with lower affinity to the S22P Cby peptide compared to the WT 14-3-3z (ΔΔG ~ 1.0 kcal/
mol) (Table 1, S4 Fig).
Fig 1. (A) Crystal structure of the 14-3-3ζ /Cby 18-mer complex. Each 14-3-3ζmonomer (coloured orange and blue) is bound to one Cby phosphopeptide.
(B) Final 2Fo − Fc electron density of 14-3-3ζ (blue mesh) and Cby 18-mer (green mesh) contoured to 1σ. (C) Polar contacts (black hashed lines) between 14-
3-3ζ residues (light blue sticks) and the Cby 18-mer (green sticks).
doi:10.1371/journal.pone.0123934.g001
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Probe for secondary interactions between 14-3-3ζ and Cby using NMR
spectroscopy
The crystal structure of 14-3-3z/Cby complex clearly reveals the molecular basis of primary in-
teractions between 14-3-3z and the non-canonical mode II binding motif within Cby. Howev-
er, like most of the 14-3-3/phosphopeptide structures available to date, the lack of electron
density for residues outside the phosphorylated binding motif of Cby hinders our understand-
ing of the secondary interactions in complex formation. Notably, our ITC results showed that
the Cby 18-mer (12KTPPRKSA(pS)LSNLHSLDR29) used in the crystallographic study has a
significantly higher affinity compared to the 7-mer (16RKSA(pS)LS22; the minimal 14-3-3
binding motif) for 14-3-3z. However, only residues 23NLH25 outside the minimal binding
motif were observable in the crystal structure. Of the three, only the L24 side-chain is buried
within the interface, projecting toward a hydrophobic patch consisting of 14-3-3z residues
Fig 2. Structural comparison of 14-3-3ζ-bound Cby with other 14-3-3 binding motifs comprising various +2 residues.Residues K49 and R56 are
coloured yellow on the white surface representation of 14-3-3ζ. Structural and sequence alignment of Cby (green sticks) with the binding-motifs of (A). Raf1
(pink sticks, PDB: 3CU8), (B) PKCε (orange sticks, PDB: 2WH0), (C) Histone H3 (white sticks, PDB: 2C1N), (D) β2 integrin (blue sticks, PDB: 2V7D) and (E)
α 4 integrin (purple sticks. PDB: 4HKC). The Cα RMSD values were computed by subtracting a Cα distance matrix between the -2 and +1 residues of Cby
and each peptide as well as the -2 and most C-terminal residue in the respective alignments.
doi:10.1371/journal.pone.0123934.g002
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L216 and I217. Intriguingly, immunoprecipitation experiments performed by Li et al.[14] dem-
onstrated that an alanine substitution at L24 on Cby abolished binding to 14-3-3z. Our ITC ti-
trations with the Cby 18-mer comprising the L24A mutation revealed that its interaction with
14-3-3z was indeed impaired but not abolished, binding approximately 4-fold weaker than the
wild-type peptide with a KD ~21 μM (Table 1, S2 Fig). To gain a more thorough understanding
of the secondary interactions between 14-3-3z and Cby, we sought to determine if there are ad-
ditional regions in 14-3-3z that interact with the Cby 18-mer compared to the 7-mer using
NMR chemical shift mapping, a powerful technique for identifying binding interfaces
in solution.
Due to the relatively high molecular weight of the 14-3-3z dimer (~56 kDa), deuterated pro-
tein samples were used in our NMR studies. An initial 1H-15N TROSY-HSQC spectrum of 14-
3-3z displayed many well-dispersed resonance signals along with a small number of extremely
intense peaks (S5 Fig). These strong peaks do not display any chemical shift changes upon titra-
tion of the unlabeled 18-mer Cby peptide, indicating that their corresponding residues are not
involved in the interaction (S5 Fig). However, their presence in the 1H-15N TROSY-HSQC spec-
trum unavoidably complicates the spectral analysis by masking many underlying resonances.
We speculated that these high intensity resonances originate from 14-3-3z’s C-terminal tail,
which has been shown to be disordered [35]. With this in mind, we have generated the 14-3-
3zΔC12 construct, which is full-length 14-3-3z with the C-terminal 12 residues being removed.
The 1H-15N TROSY-HSQC of 14-3-3zΔC12 overlays almost perfectly with that of 14-3-3z, ex-
cept that the highly intense peaks are no longer observable, confirming that these resonances
originate from the C-terminal tail. Importantly, ITC experiments show that 14-3-3zΔC12 binds
to Cby peptides with almost the same affinity as full-length 14-3-3z (Table 1, S6 Fig).
Backbone resonance assignments for 1HN, 15N, 13Cα and 13Cβ were obtained for 14-3-
3zΔC12 (Fig 3A). We were able to assign 82% of the 1HN and 15N resonances of non-proline
residues, 81% of all 13Cα and 81% all 13Cβ resonances. The presence of weak peaks prevented a
higher percentage of resonance assignments. The residue-specific secondary structure propen-
sity (SSP) scores using 13Cα/β chemical shifts [36] indicate that the protein is, as expected,
largely α-helical (Fig 3B).
Mapping the Cby peptides binding regions on 14-3-3ζΔC12
The nearly complete backbone assignment of 14-3-3zΔC12 affords an opportunity to map the
binding regions of different Cby peptides on 14-3-3z in a highly efficient manner. The 7-mer
and 18-mer Cby peptides were titrated to 14-3-3zΔC12 in a series of NMR experiments to a
final molar ratio of 3:1 (peptide:protein) for chemical shift mapping (Fig 4A). When comparing
the 1H-15N TROSY-HSQC spectra of 14-3-3zΔC12 in the apo and the 7-mer/18-mer Cby
bound forms, a large number of chemical shift changes as well as peak broadenings are ob-
served. The chemical shift perturbations were calculated for both titration sets and were mapped
onto the 14-3-3z/Cby structure (Fig 5B & 5C, S7A Fig). From the generated maps, the residues
exhibiting the largest chemical shift changes for both peptides are found within helices αC, αE
and αI, matching well with the binding interface observed in the crystal structure (Fig 5A). Ad-
ditional peaks within the binding cleft were broadened out over the course of the titrations. For
the Cby 18-mer titration, these peaks include M121, D124, Y125 and A130 within αE, L170,
L172, V176 and Y178 within αG, and I217, L220 and R222 within αI. Broadened resonances
within the binding cleft are similar for the Cby 7-mer titration, including F117, M121, D124 and
A130 within αE, L170, L172, V176, F177 and Y178 within αG, and Y211 within αI. Even though
residues that bond with the phosphate group of S20 on Cby, R56, R127 and Y128, could not be
assigned, residues surrounding this basic patch either broaden out (M121, D124, Y125, V176)
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or exhibit large chemical shift changes (V52, G53) as expected. Large chemical shift perturba-
tions or broadened resonances were not observed along the 14-3-3z dimer interface for
either peptide.
Notably, the Cby 18-mer binding interface appears to be larger than that of the pCby 7-mer.
Many 14-3-3z residues within the loop between αH and αI (204–208), along with N-terminal
residues of αI (209–215) exhibit larger chemical shift perturbations when titrated with the Cby
Fig 3. (A) 1H-15N TROSY-HSQC spectrum and backbone resonance assignment of 2H/13C/15N labeled 14-3-3ζΔC12. (B) Secondary structure propensity
(SSP) scores for 14-3-3ζΔC12. SSP scores were calculated based upon the 13Cα/β chemical shifts.
doi:10.1371/journal.pone.0123934.g003
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18-mer compared to the Cby 7-mer (S8 Fig). Based on the orientation of the peptide, we specu-
late that this region of 14-3-3 interacts with the C-terminal (26SLDR29) residues on the Cby
18-mer peptide.
Additional NMR titration experiments were performed with the Cby S22P 18-mer to com-
pare its binding interface with theWT. The chemical shift analysis (S7B Fig) and subsequent
mapping onto the 14-3-3z/Cby structure (Fig 5D) revealed a similar interface to that observed
for the CbyWT 18-mer. Interestingly, while the resonance signals of some residues in the αH—
αI loop and residues within the 209–215 range in αI shift similarly when titrated with theWT
or S22P peptides, the T205, L206, E209 and S210 peaks have much smaller shifts when titrated
with the Cby S22P 18-mer. Having a proline at the +2 position may affect how the downstream
C-terminal residues interact with this loop region.
Discussion
The molecular basis of the interaction between 14-3-3z and Cby was extensively investigated
by using a combination of X-ray crystallography, NMR spectroscopy, and ITC. Our ITC results
show that even though phosphorylation of Cby-S20 is critical for the complex formation (as
Cby peptides comprising S20D and S20E phospho-mimetics failed to bind to 14-3-3z), residues
Fig 4. NMR titration experiments of 14-3-3ζΔC12 with Cby peptides. (A) 1H-15N TROSY-HSQC spectra of 14-3-3ζΔC12 alone (black) and with 3 molar
equivalents of the Cby 7-mer (red) and Cby 18-mer (blue). (B) 1H-15N TROSY-HSQC spectra of 14-3-3ζΔC12 alone (black) and with 3 molar equivalents of
theWT Cby 18-mer (blue) and Cby S22P 18-mer (blue).
doi:10.1371/journal.pone.0123934.g004
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outside the 14-3-3 binding-motif also play an important role in the interaction. This is sup-
ported by the finding that a short, 7-residue phosphopeptide of Cby comprising the minimal
14-3-3 binding-motif bound 10-fold weaker compared to a longer, 18-residue phosphopeptide.
A similar observation was made in a recent study of 14-3-3/α-integrin tail complexes, demon-
strating that a 30-residue α4-integrin peptide comprising its 14-3-3-binding motif bound up to
15 times tighter to 14-3-3z than an 11-residue peptide [34]. Interestingly, in the same study,
short and long phosphopeptides comprising the 14-3-3 binding motif for the β2-integrin
bound with nearly the same high affinity, suggesting that secondary interactions from flanking
residues are likely sequence specific.
Another interesting finding from our ITC experiments is that the phosphorylated Cby pep-
tides comprising a mutation at the pS + 2 position to the canonical proline (S22P) bind ~15 fold
tighter than theWT peptides. Our crystal structure provides molecular insight into the target
binding specificity of 14-3-3. Based on available crystal structures of various 14-3-3 isoforms in
complex with phosphorylated peptides comprising type I or type II binding motifs (for example,
PDB: 1QJA [37], 1QJB [37], 3MHR [38]), the K49 (z sequence) side chain commonly forms a
hydrogen bond with the phosphate group on pSer. However, in the 14-3-3z/Cby crystal
Fig 5. Themapping of chemical shifts on the crystal structure of the 14-3-3ζ /Cby complex.Due to the crowding of some peaks, the chemical shifts of
some residues could not be confidently traced and were excluded from the analysis. (A) (Above) A monomer of the 14-3-3ζ /Cby crystal structure interface
based on Cby residues (18SApSLSNLH25). Residues R56, R127 and Y128 which contact the Cby phosphate group are coloured red, residues interfacing the
peptide are coloured cyan, and 14-3-3ζ residues coloured magenta are found along the 14-3-3 dimer interface. (Below) The 14-3-3ζ dimer bound to Cby. (B)
(Cby 7-mer), (C) (Cby 18-mer) and (D) (Cby S22P 18-mer). Residues with traceable assigned resonances are coloured on a blue—white—yellow gradient
(0 ppm to 0.1 ppm) based on their combined chemical shift [Δω = ((Δδ1H)2 +(0.2*Δδ15N)2)1/2] at a 3:1 peptide:protein ratio. Residues coloured in orange
represent peaks that broadened out to disappearance upon addition of peptide. Residues R56, R127 and Y128 are coloured pink.
doi:10.1371/journal.pone.0123934.g005
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structure, the side chain of S22 positions between K49 and R56 of 14-3-3z and sterically hinders
the interaction between K49 and pS20. Interestingly, introducing K49Amutation to 14-3-3z
does not affect its affinity for theWT Cby peptide, but the binding affinity to the S22P peptide
was reduced by ~5 fold. From these results, we speculate the S22P mutation of Cby promotes a
conformational change in the bound state, allowing K49 on 14-3-3z to form hydrogen bond
with the phosphate group on S20. However, it should be noted that there are examples of pep-
tides containing a +2 proline co-crystallized with 14-3-3 proteins where K49 is either not mak-
ing any direct contacts with the ligand (PDB: 4FL5) or it interacts with other residues within the
phosphopeptides (PDB: 3UAL [39], 4IEA [40]) instead of the phosphorylation site. Additional-
ly, a proline at the +2 position is not absolutely essential for a K49—phosphate group interac-
tion. This contact is observed in the 14-3-3γ/tyrosine hydroxylase structure (PDB: 4J6S [41])
and in the 14-3-3z/alpha-4 integrin, which both have a leucine at the +2 position.
With only 8 of the 18 residues in the Cby 18-mer peptide resolved in the crystal structure, it
is likely that any secondary contacts made by flanking residues are very dynamic. This is a
common issue in the co-crystallization of 14-3-3 proteins and peptides. Typically, only short
regions (4–10 residues comprising residues nearby the pS/pT) within longer phosphopeptides
are resolved. Because significant secondary interactions may be critical to 14-3-3z’s interaction
with Cby, we elected to pursue NMR spectroscopy as a means of further characterizing
the complex.
Chemical shift analysis of 1H-15N TROSY-HSQC titration experiments, performed by ti-
trating the 7-mer and 18-mer Cby peptides into isotopically labeled 14-3-3zΔC12, allowed for
chemical shift mapping to reveal any differences in the binding interface between both pep-
tides. We found that 14-3-3z residues 204–215 are involved in the interaction with the Cby
18-mer but not the 7-mer. Based on the orientation of the peptide in the crystal structure, this
would correspond to the residues C-terminal to the pS20, 23NLHSLDR29, making transient
contacts with this region of 14-3-3z. Chemical shift analysis of the Cby S22P 18-mer bound to
14-3-3zΔC12 revealed a similar binding site to that of the WT 18-mer, however some variabili-
ty in shifts for residues within the 204–215 range were observed. This suggests that the +2 resi-
due can affect how downstream C-terminal residues interact with 14-3-3z. A +2 proline is of
particular interest because while it is most commonly observed bound in a trans conformation
(e.g. 1QJA [37]) it has been observed bound in the cis conformation (e.g. 1QJB [37]).
Residues 203–210, corresponding to 14-3-3z’s αH- αI linker, have been shown to be part of
a secondary binding site with another 14-3-3 target [30]. The crystal structure of the 14-3-3z/
phosphorylated-AANAT complex, the only full-length protein to be solved in complex with
14-3-3, demonstrates that this linker is used by 14-3-3z to bind AANAT, highlighted by the
14-3-3z residue E208 making a salt bridge with R53 of phosphorylated AANAT, located in the
globular region of the protein. Additionally, this linker region has been implicated in ligand
discrimination between 14-3-3 isoforms [42,43]. For instance, the phosphatase Cdc25C can
bind to all 14-3-3 isoforms except for σ; however, the mutation of divergent residues within
14-3-3σ’s αH- αI linker to those conserved across all other isoforms enables the engineered σ
to bind Cdc25C [43].
Building on this work, future studies are in progress to elucidate how the complex forms in
the context of full-length Cby. It is conceivable that two Cby molecules could retain a coiled-
coil structure while each is bound to 14-3-3z (Fig 6). Because of the orientation each 14-3-3z
monomer adopts upon dimerization, the Cby residues lying on the C-terminal end of serine 20
will exit the binding interface at opposing ends of the 14-3-3z dimer. Since the N-terminal resi-
dues (1–64) of full-length Cby are disordered [19] it is feasible that each bound Cby molecule
retains the flexibility necessary to orient itself to form a coiled-coil from residues 73–100, as
well as to bind to the 88-kDa β-catenin. The model (Fig 6) is consistent with the results of Li
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et al.[13], which demonstrated that binding of Cby to β-catenin is not interfered by the in-
creased level of 14-3-3. We are aware that a Cby dimer binding to the 14-3-3 dimer could pre-
sumably lead to a stronger interaction between the two molecules than what was reported in
this study due to avidity. How the complex ultimately forms, i.e. its stoichiometry and confor-
mation, will aid in providing the mechanistic basis by which the two proteins recruit β-catenin
to form a trimolecular complex and promote β-catenin’s nuclear exclusion.
Also of interest is the interplay of Cby’s interactions with 14-3-3 and CRM1. Cby’s 14-3-3
binding motif is juxtaposed with its nuclear export signal (NES) (21LSNLHSLDR29). Immuno-
precipitation experiments by Li et al. [14] revealed that 14-3-3 enhanced the Cby-CRM1 interac-
tion in a dose-dependent manner. It was postulated that 14-3-3 might induce a conformational
change in Cby to expose its NES for CRM1 recruitment. In doing so, CRM1 could then mediate
the nuclear exclusion of Cby. Our crystal structure demonstrates that this mechanism may not
be the case. The consensus NES sequence isF1(X2–3)F
2(X2–3)F
3XF4, whereF represents critical
hydrophobic residues L, I, V, F or M and X is any amino acid[44,45]. In determined crystal struc-
tures of CRM1/target complexes, the critical hydrophobic residues are buried in a hydrophobic
cleft formed by HEAT repeats 11 and 12 of CRM1[46,47]. The hydrophobic residues on Cby’s
NES correspond to L21, L24 and L27. From our 14-3-3/Cby crystal structure, the L21 and L24
sidechains are projected toward 14-3-3’s binding cleft, making them inaccessible for CRM1. Resi-
dues (26SLDR29) are unobservable in our structure and thus their accessibility remains unknown.
Fig 6. The 14-3-3ζ, Cby, β-catenin tripartite complex.Model of dimeric 14-3-3ζ bound to two molecules of
full-length Cby. The models of two full-length Cby proteins have disordered residues 30–73 of the N-terminus
and 100–126 of the C-terminus presented in a highly extended fashion, and are shown forming a coiled-coil
from residues 73–100. β-catenin (PDB: 2Z6H) is shown with its Cby binding-site (helix C) in red which then
binds along the C-terminus (64–126) of Cby.
doi:10.1371/journal.pone.0123934.g006
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However, Li et al. [14] demonstrated that a L27Amutation to Cby did not affect the Cby/CRM1
interaction, and showed normal, WT subcellular distribution. Meanwhile, L21A and L24Amuta-
tions abolished the interaction with CRM1 and led to the nuclear sequestration of Cby. As such,
14-3-3 may need to be dissociated from Cby to allow for the CRM1 interaction. Further cell ex-
periments and structural studies of the Cby/CRM1 complex are needed to comprehend how 14-
3-3 and CRM1 work in concert to promote the cytoplasmic sequestration of Cby.
Finally, NMR studies are critical to the characterization of 14-3-3 interactions as their inter-
actome is predicted to predominantly consist of disordered targets [27]. The backbone reso-
nance assignment of 14-3-3z completed in this work therefore not just facilitate the studies of
14-3-3z with Cby, it will be invaluable for probing interactions between 14-3-3z and a continu-
ally growing list of protein targets by NMR. Such studies may allow the identification of ligand-
binding interfaces on 14-3-3 in an efficient manner as illustrated in this work. Moreover, with
14-3-3z over-expression associated with tumour progression and chemoresistance (reviewed in
Matta et al. [48]), the protein is an attractive therapeutic target in cancer. With the availability
of the backbone resonance assignment of 14-3-3z, NMR titration can be a quick way to test the
binding/determine the binding site of small molecule or peptide 14-3-3 inhibitors [49,50]. Simi-
larly, this may also be done for a number of recently discovered 14-3-3 protein-protein small-
molecule stabilizers [49,50], which offer an alternative approach to modulating 14-3-3 activity.
Materials and Methods
Expression and purification of 14-3-3ζ
The human14-3-3zORF purchased from GeneCopoeia was transferred into Gateway
pDEST17 vector (Invitrogen). The 14-3-3zΔC12, where the 12 C-terminal residues were delet-
ed, was then generated from the full-length construct using QuikChange II Site-Directed Muta-
genesis Kit (Strategene). Both full-length 14-3-3z and 14-3-3zΔC12 were expressed as N-
terminally His-tagged protein in Escherichia coli (E. coli) BL21 (DE3) pLysS in M9 medium.
For unlabeled protein, protein expression was induced at an O.D.600 of 0.9 by adding 0.75 mM
IPTG at 18°C for 24 h. The 15N, 13C, 2H labeled 14-3-3zΔC12 was produced by growing E. coli
in deuterated M9 medium. Cells adapted to 70% D2O were used to inoculate a 1 L culture of
M9 prepared in 100% D2O. Cells were grown at 37°C and overexpression was induced at an O.
D.600 of 0.6 with 0.75 mM IPTG. After a 60-h induction at 18°C, the cells were harvested. All
14-3-3z constructs used in this study were purified from the crude lysate by affinity chromatog-
raphy using Ni Sepharose Fast Flow beads (Amersham Biosciences). The tag was then cleaved
by overnight incubation with His-tagged tobacco etch virus (TEV) protease at 25°C. The
cleaved 14-3-3z, which retains an N-terminal glycine, was purified by passing the mixture
through Ni Sepharose Fast Flow beads. The final yields for the 14-3-3z proteins were ~50 mg
per L of M9 media (including deuterated media).
Peptide Synthesis
The Cby peptides used in this study were purchased from GenScript USA Inc. and the TUFTS
University Core Facility. From GenScript USA Inc.: Cby 13-mer (NH2-
12KTPPRKSASLSNL24-
COOH), Cby S20D 13-mer (NH2-
12KTPPRKSADLSNL24-COOH), Cby S20E 13-mer
(NH2-
12KTPPRKSAELSNL24-COOH), pCby 13-mer (NH2-
12KTPPRKSApSLSNL24-COOH)
and pCby 18-mer ((NH2-
12KTPPRKSApSLSNLHSLDR29-COOH). From TUFTS: pCby 7-mer
(Ac-16RKSApSLS22-NH2), pCby 11-mer (NH2-
12KTPPRKSApSLS22-NH2), pCby S22P 7-mer
(Ac-16RKSApSLP22-NH2), pCby S22P 13-mer (NH2-
12KTPPRKSApSLPNL24-COOH)
and pCby S22P 18-mer (NH2-
12KTPPRKSApSLSNLHSLDR29-COOH). Peptides were
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dissolved and dialyzed in 50 mM sodium phosphate, 100 mM NaCl at pH 6.8 for ITC and
NMR experiments.
Crystallization and Structure Determination
Crystals grew within 2 months at 4°C in sitting drops containing 1 μL of complexed 14-3-3z
(10 mg/mL) and phosphorylated Cby 18-mer peptide (protein:peptide ratio 1:4) in 20 mM
Tris, pH 7.5, and 100 mMNaCl and 1 μL of reservoir solution containing 200 mMNH4HCO2
and 16–20% PEG 3350. The mother liquor with 15% glycerol served as the cryoprotectant for
flash-cooling in liquid nitrogen. Data were collected at the Macromolecular Crystallographic
Facility (University of Western Ontario). The structure was solved via rigid body molecular re-
placement, using Protein Data Bank entry 1QJA [37] as the starting model. The Cby peptide
was built manually using Coot [51] and refinement was carried out using PHENIX [52].
NMR Experiments
All NMR experiments were performed using 15N, 13C, 2H-labeled protein samples in 50 mM
sodium phosphate, 100 mMNaCl at pH 6.8. Samples contained 10% D2O and 1 mM 2,2-di-
methyl-2-sila-pentane-5-sulfonic acid (DSS) as 1H chemical shift reference. NMR experiments
for the backbone resonance assignment of 14-3-3zΔC12 were conducted at 25°C on a Bruker
Avance 800 MHz (Singapore) spectrometer equipped with cryogenic probe. Sequential assign-
ments were obtained from 1H-15N TROSY HSQC, HNCACB, HN(CO)CACB and 15N-NOE-
SY-HSQC spectra. Data were processed using NMRPipe [53] and analyzed using CARA [54].
For the NMR titrations, either phosphorylated Cby 7-mer or 18-mer peptides were titrated
into 600 μL of ~ 200 μM 15N, 13C, 2H labeled 14-3-3zΔC12 until a 3:1 (peptide: 14-3-3zΔC12)
molar ratio was reached. A 1H-15N HSQC spectrum was collected for each titration point for a
total of 12 points for the pCby WT 7-mer and 18-mer and 6 points for the pCby S22P 18-mer.
All spectra were analyzed using NMRView [55].
Isothermal titration calorimetry (ITC) experiments
ITC experiments were performed on a VP-ITC instrument (MicroCal) at 25°C. The protein and
peptide samples were dialyzed into a buffer containing 50 mM sodium phosphate, 100 mM
NaCl, 1 mMDTT at pH 6.8 and degassed before the experiments. In a typical experiment, 5 μL
aliquots of ~1–2 mM peptide were titrated stepwise into the 1.4 mL sample cell containing
~100–200 μM 14-3-3z. The association constant (Ka), molar binding stoichiometry (n) and the
binding enthalpy (ΔH), entropy (ΔS) and Gibbs free energy (ΔG) were determined by fitting the
binding isotherm to a one-site model with MicroCal Origin7 software. All ITC experiments
were performed in duplicate. A duplicate set of thermodynamic derived binding parameters are
found in S1 Table. Peptide and protein concentrations were determined from amino acid analy-
sis (Amino Acid Analysis Facility, SickKids, Toronto, ON).
Accession Numbers
The atomic coordinates for the 14-3-3z/Cby complex have been deposited in the Protein Data
Bank under accession number 4WRQ. The 1H, 15N and 13Cα/β chemical shifts of the backbone
resonances have been deposited in the BioMagResBank (http://www.bmrb.wisc.edu), under
BMRB accession number 25231.
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Supporting Information
S1 Fig. ITC thermograms for titrations of unphosphorylated or phospho-mimetic Cby pep-
tides to 14-3-3z. (A) CbyWT 13-mer. (B) Cby S20D 13-mer. (C) Cby S20E 13-mer.
(TIF)
S2 Fig. ITC thermograms for various phosphorylated WT and mutant Cby peptides titrat-
ed into 14-3-3z. (A) Cby 7-mer. (B) Cby 11-mer. (C) Cby 13-mer. (D) Cby 18-mer. (E) Cby
S22P 7-mer (F) Cby S22P 13-mer. (G) Cby S22P 18-mer. (H) Cby L24A 18-mer.
(TIF)
S3 Fig. A comparison of the orientation of 14-3-3z’s K49 side-chain in the 14-3-3z/Cby and
14-3-3z/Raf1 (PDB: 3CU8) complexes. Cby is represented by the green sticks and Raf1 by the
light pink sticks. K49 in the 14-3-3z/Cby and 14-3-3z/Raf1 complexes is shown in yellow and
dark pink, respectively.
(TIF)
S4 Fig. ITC thermograms for the (A) WT Cby 18-mer and (B) Cby S22P 18-mer titrated to
14-3-3z K49A.
(TIF)
S5 Fig. 1H-15N TROSY-HSQC of 2H/13C/15N 14-3-3z in the absence (blue) and presence of
a 1:1 molar ratio of the Cby 18-mer (red). Circled resonances represent the intense signals
arising from 14-3-3z’s disordered C-terminal tail. A zoomed-in view displays the intense sig-
nals derived from 14-3-3z’s disordered C-terminal tail.
(TIF)
S6 Fig. ITC thermograms for the (A) Cby 13-mer and (B) Cby 18-mer titrated to 14-3-
3zΔC12.
(TIF)
S7 Fig. Composite 1HN and
15N chemical shift perturbation [Δω = ((Δδ1H)2 +(0.2Δδ15N)2)1/2]
analysis of 14-3-3zΔC12 in the presence of three molar equivalents of the (A) Cby 7-mer,
(A + B) Cby 18-mer and (B) Cby S22P 18-mer. Due to the crowding of some peaks, the
chemical shifts of some residues could not be confidently traced and were excluded from
the analysis.
(TIF)
S8 Fig. Observed chemical shifts for 14-3-3zΔC12 residues 204–215. Resonances shown for
each residue include the apo state (black), Cby 18-mer bound-state (blue) and the pCby 7-mer
bound-state (red), at a 3:1 (pCby: 14-3-3zΔC12) ratio. Residue Y211 is displayed at a 1.25:1
(Cby: 14-3-3zΔC12) ratio as it broadens out to disappearance at a 3:1 ratio with the Cby 7-mer.
The Cby-18-mer bound-state is shown in cyan with the 7-mer bound-state in magenta.
(TIF)
S1 Table. Duplicate set of thermodynamic parameters for the binding of phosphorylated
Cby peptides to 14-3-3z.
(DOCX)
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